KIAA1199 and its biological role in human cancer and cancer cells (Review)

Zhang,Yongsheng; Jia,Shuqin; Jiang,Wen G.

doi:10.3892/or.2014.3038

KIAA1199 and its biological role in human cancer and cancer cells (Review)

Authors:
- Yongsheng Zhang
- Shuqin Jia
- Wen G. Jiang
View Affiliations

Affiliations: Laboratory of Surgery, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050, P.R. China, Cardiff University-Peking University Joint Cancer Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK
Published online on: February 20, 2014 https://doi.org/10.3892/or.2014.3038
Pages: 1503-1508

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

KIAA1199 is a gene included in the Human Unidentified Gene-Encoded (HUGE) large protein database which contains more than 2,400 members identified in the Kazusa cDNA sequencing project. Early studies described KIAA1199 as an inner ear-specific protein in which 3 point mutations were found to be associated with non‑syndromic hearing loss. Recently, KIAA1199 has been found to play a central role in hyaluronan binding and depolymerisation, and a small number of studies indicate its senescence/apoptosis-promoting role. An increasing body of evidence suggests its involvement in cancer progression, metastasis and poor prognosis of patients with cancer as determined in clinical studies. It has also been shown, in vitro, that KIAA1199 influences the proliferation, adhesion, motility, invasiveness and epithelial-to-mesenchymal transition of cancer cells. Pathway signalling analysis found that KIAA1199 is a likely target gene of the Wnt/β-catenin signalling pathway. Therefore, KIAA1199 may be a new and prospective target for cancer therapy, although further in vitro and in vivo investigations are required.

View Figures

View References

1	Suyama M, Nagase T and Ohara O: HUGE: a database for human large proteins identified by Kazusa cDNA sequencing project. Nucleic Acids Res. 27:338–339. 1999. View Article : Google Scholar : PubMed/NCBI
2	Kikuno R, Nagase T, Nakayama M, et al: HUGE: a database for human KIAA proteins, a 2004 update integrating HUGEppi and ROUGE. Nucleic Acids Res. 32:D502–D504. 2004. View Article : Google Scholar : PubMed/NCBI
3	Nagase T, Ishikawa K, Kikuno R, Hirosawa M, Nomura N and Ohara O: Prediction of the coding sequences of unidentified human genes. XV The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 6:337–345. 1999. View Article : Google Scholar
4	Michishita E, Garcés G, Barrett JC and Horikawa I: Upregulation of the KIAA1199 gene is associated with cellular mortality. Cancer Lett. 239:71–77. 2006. View Article : Google Scholar : PubMed/NCBI
5	Abe S, Usami S and Nakamura Y: Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters’ cells and the fibrocytes, as the cause of nonsyndromic hearing loss. J Hum Genet. 48:564–570. 2003.PubMed/NCBI
6	Guo J, Cheng H, Zhao S and Yu L: GG: a domain involved in phage LTF apparatus and implicated in human MEB and non-syndromic hearing loss diseases. FEBS Lett. 580:581–584. 2006. View Article : Google Scholar : PubMed/NCBI
7	He QY, Liu XH, Li Q, Studholme DJ, Li XW and Liang SP: G8: a novel domain associated with polycystic kidney disease and non-syndromic hearing loss. Bioinformatics. 22:2189–2191. 2006. View Article : Google Scholar : PubMed/NCBI
8	Kuscu C, Evensen N, Kim D, Hu YJ, Zucker S and Cao J: Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer. PLoS One. 7:e446612012. View Article : Google Scholar : PubMed/NCBI
9	Sabates-Bellver J, Van der Flier LG, de Palo M, et al: Transcriptome profile of human colorectal adenomas. Mol Cancer Res. 5:1263–1275. 2007. View Article : Google Scholar
10	Birkenkamp-Demtroder K, Maghnouj A, Mansilla F, et al: Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br J Cancer. 105:552–561. 2011. View Article : Google Scholar : PubMed/NCBI
11	Tiwari A, Schneider M, Fiorino A, et al: Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors. PLoS One. 8:e694732013. View Article : Google Scholar : PubMed/NCBI
12	Matsuzaki S, Tanaka F, Mimori K, Tahara K, Inoue H and Mori M: Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer. Ann Surg Oncol. 16:2042–2051. 2009.
13	Usami S, Takumi Y, Suzuki N, et al: The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea. Neuroscience. 154:22–28. 2008.
14	Abe S, Katagiri T, Saito-Hisaminato A, et al: Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet. 72:73–82. 2003.
15	Voronkov A and Krauss S: Wnt/beta-catenin signaling and small molecule inhibitors. Curr Pharm Des. 19:633–664. 2013. View Article : Google Scholar
16	Katanaev VL, Ponzielli R, Sémériva M and Tomlinson A: Trimeric G protein-dependent frizzled signaling in Drosophila. Cell. 120:111–122. 2005. View Article : Google Scholar : PubMed/NCBI
17	Ma L and Wang HY: Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca²⁺ pathway. J Biol Chem. 281:30990–31001. 2006. View Article : Google Scholar : PubMed/NCBI
18	Kestler HA and Kühl M: From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc Lond B Biol Sci. 363:1333–1347. 2008. View Article : Google Scholar : PubMed/NCBI
19	Nakayama M, Kikuno R and Ohara O: Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs. Genome Res. 12:1773–1784. 2002. View Article : Google Scholar
20	Zachary IC, Frankel P, Evans IM and Pellet-Many C: The role of neuropilins in cell signalling. Biochem Soc Trans. 37:1171–1178. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ramer R, Walther U, Borchert P, Laufer S, Linnebacher M and Hinz B: Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib. J Lipid Res. 54:3116–3129. 2013. View Article : Google Scholar : PubMed/NCBI
22	Abdelrahim M and Safe S: Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol. 68:317–329. 2005.
23	Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and Dou KF: The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci. 58:1016–1025. 2013. View Article : Google Scholar : PubMed/NCBI
24	Que W, Li S and Chen J: NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells. Mol Med Rep. 7:1641–1645. 2013.PubMed/NCBI
25	Galamb O, Spisák S, Sipos F, et al: Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. Br J Cancer. 102:765–773. 2010. View Article : Google Scholar : PubMed/NCBI
26	Evensen NA, Kuscu C, Nguyen HL, et al: Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration. J Natl Cancer Inst. 105:1402–1416. 2013. View Article : Google Scholar : PubMed/NCBI
27	Jia S, Ji J and Jiang WG: KIAA1199 knockdown attenuate cell growth of gastric cancer cells and its over-expression is associated with disease progression in patient with gastric cancer. Eur J Cancer. 45(Suppl 2): S5752013.
28	Usami S, Wagatsuma M, Fukuoka H, et al: The responsible genes in Japanese deafness patients and clinical application using Invader assay. Acta Otolaryngol. 128:446–454. 2008. View Article : Google Scholar : PubMed/NCBI
29	Dash DP, Silvestri G and Hughes AE: Fine mapping of the keratoconus with cataract locus on chromosome 15q and candidate gene analysis. Mol Vis. 12:499–505. 2006.PubMed/NCBI
30	Chivu Economescu M, Necula LG, Dragu D, et al: Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology. 57:1453–1464. 2010.PubMed/NCBI
31	LaPointe LC, Pedersen SK, Dunne R, et al: Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS One. 7:e290592012. View Article : Google Scholar : PubMed/NCBI
32	Paunu N, Lahermo P, Onkamo P, et al: A novel low-penetrance locus for familial glioma at 15q23–q26.3. Cancer Res. 62:3798–3802. 2002.PubMed/NCBI
33	Zweemer RP, Ryan A, Snijders AM, et al: Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab Invest. 81:1363–1370. 2001. View Article : Google Scholar
34	Stanton SE, Shin SW, Johnson BE and Meyerson M: Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer. 27:323–331. 2000. View Article : Google Scholar : PubMed/NCBI
35	Chanthammachat P, Promwikorn W, Pruegsanusak K, et al: Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Arch Oral Biol. 58:1677–1685. 2013. View Article : Google Scholar : PubMed/NCBI
36	Raish M, Khurshid M, Ansari MA, et al: Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. J Cancer Res Clin Oncol. 138:1173–1186. 2012. View Article : Google Scholar
37	Motaln H, Gruden K, Hren M, et al: Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma. Cell Transplant. 21:1529–1545. 2012. View Article : Google Scholar : PubMed/NCBI
38	Raymond F, Métairon S, Kussmann M, et al: Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue. BMC Genomics. 11:1252010. View Article : Google Scholar : PubMed/NCBI
39	Harada H and Takahashi M: CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem. 282:5597–5607. 2007. View Article : Google Scholar : PubMed/NCBI
40	Csoka AB, Frost GI and Stern R: The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20:499–508. 2001. View Article : Google Scholar : PubMed/NCBI
41	Yoshida H, Nagaoka A, Kusaka-Kikushima A, et al: KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc Natl Acad Sci USA. 110:5612–5617. 2013. View Article : Google Scholar : PubMed/NCBI
42	Yoshida H, Nagaoka A, Nakamura S, Sugiyama Y, Okada Y and Inoue S: Murine homologue of the human KIAA1199 is implicated in hyaluronan binding and depolymerization. FEBS Open Bio. 3:352–356. 2013. View Article : Google Scholar : PubMed/NCBI
43	Yoshida H, Nagaoka A, Nakamura S, Tobiishi M, Sugiyama Y and Inoue S: N-terminal signal sequence is required for cellular trafficking and hyaluronan-depolymerization of KIAA1199. FEBS Lett. 588:111–116. 2013. View Article : Google Scholar : PubMed/NCBI